The evidence leans constructive8 supporting, 0 against, 0 worth knowing
Supporting
trading 46% above its 200-day average
sitting at 91% of its 52-week range, with little overhead supply from trapped buyers
up 89% over twelve months
matches growth that is speeding up, which has beaten the market by +0.79 points over 20 sessions across 57,921 past signals
9 of the scans it matches have a positive measured record
6 independent kinds of evidence agree today, which is uncommon
revenue grew 16% year on year in the quarter ending 31 December 2024
net margin has widened from 0.9% to 6.3% across four quarters
Against
nothing the data supports either way
Worth knowing
nothing the data supports either way
The most recent financials the exchange publishes for MBAPL are 20 months old, so everything above about the business is history rather than a current read.
What would change this read: a close below 111, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working6
Net profit rose 1276.7% year on year, from Rs 1 cr to Rs 18 cr.
+1276.7%Rs 1 crRs 18 cr
Profit grew faster than revenue, +1276.7% against +16.4%.
+1276.7%+16.4%
Net margin improved from 0.5% to 6.3%.
0.5%6.3%
Trading 45.5% above its 200-day average, which is the line most investors use to separate a bull phase from a bear one.
+45.5%
Up 89.2% over the past year.
+89.2%
4 different kinds of evidence point at it tonight, not 4 versions of the same one.
4 families
Needs watching
Nothing on this side tonight — not in the filings and not in the price.
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 3 of these 3 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
12 of 47 matched on 10 Sep
MBAPL matches 12 of the 47 scans today, across 6 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
MBAPL trades at 32× trailing earnings, above its median of 16× over this window — 95% more expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
The business
from the company’s filed results
These figures are 20 months old. The most recent quarter the exchange feed publishes for this company ended 2024-12-31. Treat the growth rates below as history, not as a current read — the business may look quite different now.
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 16% against the same quarter a year earlier
profit rose 1277% year on year
net margin widened from 5.0% to 6.3%
revenue rose in 3 of the last 4 quarters
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q3 FY25
31 Dec · standalone
284
27
18
2.04
6.3%
Q2 FY25
30 Sep · standalone
278
23
14
1.58
5.0%
Q1 FY25
30 Jun · standalone
200
18
11
1.31
5.7%
Q4 FY24
31 Mar · standalone
146
8
1
0.16
0.9%
Q3 FY24
31 Dec · standalone
244
7
1
0.15
0.5%
Q2 FY24
30 Sep · standalone
278
26
15
3.41
5.4%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+5.1%
Versus 200-day average+45.5%
Below 52-week high-4.9%
Above 52-week low+112.8%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)33.7
Higher closes in last 52 of 5
Six-month return+79.37%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)3.62%
Volume versus 20-day0.9x
Median daily turnoverRs 13.1 cr
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.